Revolution Medicines RVMD
NASDAQ RVMD
$199.86 +9.12 (+4.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Other Working Capital Changes (2019 - 2026)

Revolution Medicines (RVMD) posted Other Working Capital Changes of $30.5 million for Q2 2026, up 191.66% on a QoQ basis from $10.5 million in Q1 2026, and up 150.35% year-over-year from $12.2 million in Q2 2025.

Analysis

Revolution Medicines (RVMD) Other Working Capital Changes (2019 - 2026) Analysis & Trends

Revolution Medicines has reported Other Working Capital Changes for 8 years, with the latest figure at $30.5 million in Q2 2026.

  • On a quarterly basis, Other Working Capital Changes rose 150.35% year-over-year to $30.5 million in Q2 2026; TTM through Jun 2026 was $44.9 million, a 587.88% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, changed 0.32% from the prior year.
  • Other Working Capital Changes was $30.5 million for Q2 2026 at Revolution Medicines, up from $10.5 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $6.4 million in Q3 2021, with the low at -$10.6 million in Q4 2022.
  • Average Other Working Capital Changes over 4 years is -$2.3 million, with a median of -$2.6 million recorded in 2020.
  • The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes jumped 4801.63% in 2022, then tumbled 967.89% in 2024.
  • Over 5 years, Other Working Capital Changes stood at -$4.6 million in 2022, then surged by 187.29% to $4.0 million in 2023, then increased by 27.7% to $5.1 million in 2024, then slumped by 33.94% to $3.4 million in 2025, then soared by 804.35% to $30.5 million in 2026.
  • The last three Other Working Capital Changes figures came in at $30.5 million (Q2 2026), $10.5 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Revolution Medicines 40.86 Bn 40.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.54 Mn
Jun 30, 2026 30.54 Mn
Mar 31, 2026 10.47 Mn
Mar 31, 2026 10.47 Mn
Dec 31, 2025 3.38 Mn
Dec 31, 2025 3.38 Mn
Sep 30, 2025 517,000.00
Sep 30, 2025 517,000.00
Jun 30, 2025 12.20 Mn
Jun 30, 2025 12.20 Mn
Mar 31, 2025 -6.43 Mn
Mar 31, 2025 -6.43 Mn
Dec 31, 2024 5.11 Mn
Dec 31, 2024 5.11 Mn
Sep 30, 2024 -4.36 Mn
Sep 30, 2024 -4.36 Mn
Jun 30, 2024 6.81 Mn
Jun 30, 2024 6.81 Mn
Mar 31, 2024 2.13 Mn
Mar 31, 2024 2.13 Mn
API Access

Revolution Medicines Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=RVMD&period=max&api_key=YOUR_API_KEY